| Literature DB >> 28616035 |
Long-Xing Xue1, Hong-Yu Liu1, Yang Cui1, Yue Dong1, Jiao-Qi Wang1, Qiu-Ye Ji2, Jin-Ting He1, Min Yao1, Ying-Ying Wang1, Yan-Kun Shao1, Jing Mang1, Zhong-Xin Xu1.
Abstract
Activin A, a member of the transforming growth factor-beta superfamily, plays a neuroprotective role in multiple neurological diseases. Endoplasmic reticulum (ER) stress-mediated apoptotic and autophagic cell death is implicated in a wide range of diseases, including cerebral ischemia and neurodegenerative diseases. Thapsigargin was used to induce PC12 cell death, and Activin A was used for intervention. Our results showed that Activin A significantly inhibited morphological changes in thapsigargin-induced apoptotic cells, and the expression of apoptosis-associated proteins [cleaved-caspase-12, C/EBP homologous protein (CHOP) and cleaved-caspase-3] and biomarkers of autophagy (Beclin-1 and light chain 3), and downregulated the expression of thapsigargin-induced ER stress-associated proteins [inositol requiring enzyme-1 (IRE1), tumor necrosis factor receptor-associated factor 2 (TRAF2), apoptosis signal-regulating kinase 1 (ASK1), c-Jun N-terminal kinase (JNK) and p38]. The inhibition of thapsigargin-induced cell death was concentration-dependent. These findings suggest that administration of Activin A protects PC12 cells against ER stress-mediated apoptotic and autophagic cell death by inhibiting the activation of the IRE1-TRAF2-ASK1-JNK/p38 cascade.Entities:
Keywords: Activin A; apoptosis; autophagy; c-Jun N-terminal kinase; endoplasmic reticulum stress; nerve regeneration; neural regeneration; p38
Year: 2017 PMID: 28616035 PMCID: PMC5461616 DOI: 10.4103/1673-5374.206649
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135